Transcriptional Control of PI3K/AKT/mTOR by piRNA-651 in Breast Carcinoma
- 1 November 2025
- journal article
- Published by InkVista Publishing House
- Vol. 29 (6) , 397-404
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- PI3K/AKT/mTOR signaling pathway: an important driver and therapeutic target in triple-negative breast cancerBreast Cancer, 2024
- The role of piRNAs in predicting and prognosing in cancer: a focus on piRNA-823 (a systematic review and meta-analysis)BMC Cancer, 2024
- PIWI-interacting RNAs in human cancerSeminars in Cancer Biology, 2021
- Piwi-interacting RNA-651 promotes cell proliferation and migration and inhibits apoptosis in breast cancer by facilitating DNMT1-mediated PTEN promoter methylationCell Cycle, 2021
- A practical toolkit to study aspects of the metastatic cascade in vitroActa Histochemica, 2020
- piRNAs: biogenesis and their potential roles in cancerCancer and Metastasis Reviews, 2020
- Biological function and molecular mechanism of piRNA in cancerPractical Laboratory Medicine, 2019
- Novel dimensions of piRNAs in cancerCancer Letters, 2013
- Altered expression of piRNAs and their relation with clinicopathologic features of breast cancerClinical and Translational Oncology, 2012
- piRNA, the new non-coding RNA, is aberrantly expressed in human cancer cellsClinica Chimica Acta, 2011